Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway
- PMID: 16365724
- DOI: 10.1007/s00125-005-0082-6
Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway
Abstract
Aims/hypothesis: We examined long-term total and cause-specific mortality in a nationwide, population-based Norwegian cohort of patients with childhood-onset type 1 diabetes.
Materials and methods: All Norwegian type 1 diabetic patients who were diagnosed between 1973 and 1982 and were under 15 years of age at diagnosis were included (n=1,906). Mortality was recorded from diabetes onset until 31 December 2002 and represented 46,147 person-years. The greatest age attained among deceased subjects was 40 years and the maximum diabetes duration was 30 years. Cause of death was ascertained by reviews of death certificates, autopsy protocols and medical records. The standardised mortality ratio (SMR) was based on national background statistics.
Results: During follow-up 103 individuals died. The mortality rate was 2.2/1000 person-years. The overall SMR was 4.0 (95% CI 3.2-4.8) and was similar for males and females. For ischaemic heart disease the SMR was 20.2 (7.3-39.8) for men and 20.6 (1.8-54.1) for women. Acute metabolic complications of diabetes were the most common cause of death under 30 years of age (32%). Cardiovascular disease was responsible for the largest proportion of deaths from the age of 30 years onwards (30%). Violent death accounted for 28% of the deaths in the total cohort (35% among men and 11% among women).
Conclusions/interpretation: Childhood-onset type 1 diabetes still carries an increased mortality risk when compared with the general population, particularly for cardiovascular disease. To reduce these deaths, attention should be directed to the prevention of acute metabolic complications, the identification of psychiatric vulnerability and the early detection and treatment of cardiovascular disease and associated risk factors.
Similar articles
-
Causes of death in childhood-onset Type 1 diabetes: long-term follow-up.Diabet Med. 2017 Jan;34(1):56-63. doi: 10.1111/dme.13114. Epub 2016 Apr 7. Diabet Med. 2017. PMID: 26996105
-
All-cause mortality in a nationwide cohort of childhood-onset diabetes in Norway 1973-2013.Diabetologia. 2015 Aug;58(8):1779-86. doi: 10.1007/s00125-015-3623-7. Epub 2015 May 14. Diabetologia. 2015. PMID: 25972232
-
Long-term mortality and retinopathy in type 1 diabetes.Acta Ophthalmol. 2010 May;88 Thesis1:1-14. doi: 10.1111/j.1755-3768.2010.01906.x. Acta Ophthalmol. 2010. PMID: 20500731
-
Mortality in childhood-onset type 1 diabetes: a population-based study.Diabetes Care. 2005 Oct;28(10):2384-7. doi: 10.2337/diacare.28.10.2384. Diabetes Care. 2005. PMID: 16186267
-
Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes.Diabetologia. 2017 Jul;60(7):1234-1243. doi: 10.1007/s00125-017-4273-8. Epub 2017 Apr 24. Diabetologia. 2017. PMID: 28439641
Cited by
-
Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation.Diabetes. 2013 Oct;62(10):3570-81. doi: 10.2337/db13-0216. Epub 2013 Jul 8. Diabetes. 2013. PMID: 23835337 Free PMC article.
-
Severe hypoglycemia predicts mortality in diabetes.Diabetes Care. 2012 Sep;35(9):1814-6. doi: 10.2337/dc12-0749. Diabetes Care. 2012. PMID: 22923682 Free PMC article. No abstract available.
-
Effectiveness-implementation hybrid type 2 trial evaluating two psychoeducational programmes for severe hypoglycaemia in type 1 diabetes: implementation study protocol.BMJ Open. 2019 Nov 14;9(11):e030370. doi: 10.1136/bmjopen-2019-030370. BMJ Open. 2019. PMID: 31727650 Free PMC article.
-
Comparison of the clinical effects of intermittently scanned and real-time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort study.J Diabetes Investig. 2022 Oct;13(10):1745-1752. doi: 10.1111/jdi.13830. Epub 2022 May 28. J Diabetes Investig. 2022. PMID: 35532954 Free PMC article.
-
The effects of candesartan on diabetes glomerulopathy: a double-blind, placebo-controlled trial.Pediatr Nephrol. 2008 Jun;23(6):947-54. doi: 10.1007/s00467-008-0745-x. Pediatr Nephrol. 2008. PMID: 18270751 Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical